Combination of deferasirox and deferoxamine in management of iron overload in myelodysplastic syndromes (MDS): An update in a hepatopatic patient

被引：0
|
作者：
Cerchione, C. [1 ]
Cerciello, G. [1 ]
Della Pepa, R. [1 ]
Pugliese, N. [1 ]
Marano, L. [1 ]
Vitagliano, O. [1 ]
Matarazzo, M. [2 ]
Pane, F. [1 ]
Alfinito, F. [1 ]
机构：
[1] Univ Naples Federico II, Hematol, Naples, Italy
[2] Univ Naples Federico II, Clincal Med, Naples, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70235-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-187
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [1] COMBINATION OF DEFERASIROX AND DEFEROXAMINE IN MANAGEMENT OF IRON OVERLOAD IN MYELODYSPLASTIC SYNDROMES (MDS): AN UPDATE IN A HEPATOPATIC PATIENT
    Cerchione, C.
    Cerciello, G.
    Della Pepa, R.
    Pugliese, N.
    Marano, L.
    Vitagliano, O.
    Matarazzo, M.
    Pane, F.
    Alfinito, F.
    HAEMATOLOGICA, 2013, 98 : 731 - 731
  • [2] Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease
    Cerchione, Claudio
    Cerciello, Giuseppe
    Avilia, Simona
    Della Pepa, Roberta
    Pugliese, Novella
    Picardi, Marco
    Catalano, Lucio
    Pane, Fabrizio
    BLOOD TRANSFUSION, 2018, 16 (01) : 32 - 35
  • [3] DEFERASIROX AND DEFEROXAMINE COMBINATION THERAPY: A CASE OF MANAGEMENT OF IRON OVERLOAD IN MYELODYSPLASTIC SYNDROME IN AN HEPATOPATHIC PATIENT.
    Cerchione, C.
    Cerciello, G.
    Della Pepa, R.
    Matarazzo, M.
    Alfinito, F.
    Pane, F.
    HAEMATOLOGICA, 2012, 97 : 713 - 713
  • [4] Iron overload in myelodysplastic syndromes (MDS)
    Norbert Gattermann
    International Journal of Hematology, 2018, 107 : 55 - 63
  • [5] Iron overload in myelodysplastic syndromes (MDS)
    Gattermann, Norbert
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) : 55 - 63
  • [6] Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes
    Wimazal, F.
    Noesslinger, T.
    Baumgartner, C.
    Sperr, W. R.
    Pfeilstoecker, M.
    Valent, P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (05) : 406 - 411
  • [7] Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
    Wu, Dijiong
    Wen, Xiaowen
    Liu, Wenbin
    Hu, Huijin
    Ye, Baodong
    Zhou, Yuhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1081 - 1091
  • [8] Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Taher, Ali
    Kantarjian, Hagop M.
    ONCOLOGIST, 2009, 14 (05): : 489 - 496
  • [9] Iron overload in myelodysplastic syndromes (MDS) -: diagnosis, management, and response criteria:: a proposal of the Austrian MDS platform
    Valent, P.
    Krieger, O.
    Stauder, R.
    Wimazal, F.
    Noesslinger, T.
    Sperr, W. R.
    Sill, H.
    Bettelheim, P.
    Pfeilstoecker, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (03) : 143 - 149
  • [10] Study of deferoxamine in subcutaneous profusion treatment of iron overload in myelodysplastic syndromes
    González, FA
    Arrizabalaga, B
    Villegas, A
    Alonso, D
    Castro, M
    Remacha, A
    del Arco, A
    Núñez, GM
    MEDICINA CLINICA, 2005, 124 (17): : 645 - 647
12345